Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Jeroen Elassaiss‐Schaap | Researchclopedia

Back to researchers

Jeroen Elassaiss‐Schaap

Utrecht University ORCID

46

Works

6,898

Citations

14

h-index

16

i10-index

Research Topics

Cancer Immunotherapy and Biomarkers Immunotherapy and Immune Responses CAR-T cell therapy research

Affiliations

Leiden University2017–2022

Merck & Co., Inc., Rahway, NJ, USA (United States)2013–2016

Utrecht University2018–2025

Merck (Netherlands)2014–2016

SNV Netherlands Development Organisation2010–2010

Top Works

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

Omid Hamid,Caroline Robert,et al.

20133,386 citations

Colorectal Cancer Treatments and Studies

Melanoma and MAPK Pathways

Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial

Caroline Robert,Antoni Ribas,et al.

20141,754 citations

Phase I Study of Pembrolizumab (MK-3475; Anti–PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors

Amita Patnaik,Soonmo Peter Kang,et al.

2015775 citations

Baseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients with Melanoma Treated with Pembrolizumab

Richard W. Joseph,Jeroen Elassaiss‐Schaap,et al.

2018305 citations

Model-Based Characterization of the Pharmacokinetics of Pembrolizumab: A Humanized Anti-PD-1 Monoclonal Antibody in Advanced Solid Tumors

Malidi Ahamadi,Tomoko Freshwater,et al.

2016147 citations

Translational Pharmacokinetic/Pharmacodynamic Modeling of Tumor Growth Inhibition Supports Dose-Range Selection of the Anti-PD-1 Antibody Pembrolizumab

Andreas Lindauer,CR Valiathan,et al.

2016119 citations

Using Model-Based “Learn and Confirm” to Reveal the Pharmacokinetics-Pharmacodynamics Relationship of Pembrolizumab in the KEYNOTE-001 Trial

Jeroen Elassaiss‐Schaap,Stefaan Rossenu,et al.

2016112 citations

Population Pharmacokinetic/Pharmacodynamic Modeling of Tumor Size Dynamics in Pembrolizumab-Treated Advanced Melanoma

MS Chatterjee,Jeroen Elassaiss‐Schaap,et al.

201680 citations

Correction: Baseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients with Melanoma Treated with Pembrolizumab

Richard W. Joseph,Jeroen Elassaiss‐Schaap,et al.

201838 citations